These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 23817299)
21. Clinical management of patients with gastric neuroendocrine neoplasms associated with chronic atrophic gastritis: a retrospective, multicentre study. Campana D; Ravizza D; Ferolla P; Faggiano A; Grimaldi F; Albertelli M; Berretti D; Castellani D; Cacciari G; Fazio N; Colao A; Ferone D; Tomassetti P Endocrine; 2016 Jan; 51(1):131-9. PubMed ID: 25814125 [TBL] [Abstract][Full Text] [Related]
22. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification. Klöppel G; Couvelard A; Perren A; Komminoth P; McNicol AM; Nilsson O; Scarpa A; Scoazec JY; Wiedenmann B; Papotti M; Rindi G; Plöckinger U; ; Neuroendocrinology; 2009; 90(2):162-6. PubMed ID: 19060454 [No Abstract] [Full Text] [Related]
23. Histologic characterization and improved prognostic evaluation of 209 gastric neuroendocrine neoplasms. La Rosa S; Inzani F; Vanoli A; Klersy C; Dainese L; Rindi G; Capella C; Bordi C; Solcia E Hum Pathol; 2011 Oct; 42(10):1373-84. PubMed ID: 21531442 [TBL] [Abstract][Full Text] [Related]
24. Clinicopathological features of primary gastric neuroendocrine neoplasms: A single-center analysis. Xu TM; Wang CS; Jia CW; Qian JM; Li JN J Dig Dis; 2016 Mar; 17(3):162-8. PubMed ID: 26860897 [TBL] [Abstract][Full Text] [Related]
26. [A clinico-pathological study of neuroendocrine tumors in stomach]. Yu J; Wang L; Wang J; Meng Y; Hu M; Zheng J Zhonghua Bing Li Xue Za Zhi; 1999 Feb; 28(1):20-3. PubMed ID: 11869506 [TBL] [Abstract][Full Text] [Related]
27. Recurrence and metastatic potential in Type 1 gastric neuroendocrine neoplasms. Daskalakis K; Tsoli M; Karapanagioti A; Chrysochoou M; Thomas D; Sougioultzis S; Karoumpalis I; Kaltsas GA; Alexandraki KI Clin Endocrinol (Oxf); 2019 Oct; 91(4):534-543. PubMed ID: 31254407 [TBL] [Abstract][Full Text] [Related]
28. Hypergastrinemia is associated with adenocarcinomas in the gastric corpus and shorter patient survival. Fossmark R; Sagatun L; Nordrum IS; Sandvik AK; Waldum HL APMIS; 2015 Jun; 123(6):509-14. PubMed ID: 25939315 [TBL] [Abstract][Full Text] [Related]
33. Do neuroendocrine cells, particularly the D-cell, play a role in the development of gastric stump cancer? Waldum HL; Haugen OA; Brenna E Cancer Detect Prev; 1994; 18(6):431-6. PubMed ID: 7867015 [TBL] [Abstract][Full Text] [Related]
34. Comparison of WHO 2000 and WHO 2010 classifications of gastroenteropancreatic neuroendocrine tumors. Karakuş E; Helvacı A; Ekinci O; Dursun A Turk J Gastroenterol; 2014 Feb; 25(1):81-7. PubMed ID: 24918137 [TBL] [Abstract][Full Text] [Related]
35. Neuroendocrine Tumors of the Stomach. Corey B; Chen H Surg Clin North Am; 2017 Apr; 97(2):333-343. PubMed ID: 28325190 [TBL] [Abstract][Full Text] [Related]
36. Effects of tumor types on treatment strategy formulation and prognostic evaluation of gastric neuroendocrine tumors. Jiao X; Wang Z; Peng X; Zhang L; Zhou L Future Oncol; 2020 Oct; 16(28):2197-2207. PubMed ID: 32687408 [No Abstract] [Full Text] [Related]
37. Gastric neuroendocrine neoplasms: tumour clonality and malignancy-associated large X-chromosomal deletions. D'Adda T; Candidus S; Denk H; Bordi C; Höfler H J Pathol; 1999 Nov; 189(3):394-401. PubMed ID: 10547602 [TBL] [Abstract][Full Text] [Related]